Cleared Traditional

K062916 - CLINIQA LIQUID QC CARDIAC MARKER CONTROL SP, LEVELS 1,2, &3

K062916 is an FDA 510(k) clearance for CLINIQA LIQUID QC CARDIAC MARKER CONTROL SP, manufactured by Cliniqa Corporation. The device is a Class 1 Chemistry device with product code JJY cleared through the Traditional 510(k) pathway after a 25-day FDA review.

K062916 · Cliniqa Corporation · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2006
Decision
25d
Days
Class 1
Risk

K062916 is an FDA 510(k) clearance for the CLINIQA LIQUID QC CARDIAC MARKER CONTROL SP, LEVELS 1,2, &3. Classified as Multi-analyte Controls, All Kinds (assayed) (product code JJY), Class I - General Controls.

Submitted by Cliniqa Corporation (Fallbrook, US). The FDA issued a Cleared decision on October 23, 2006 after a review of 25 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1660 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Cliniqa Corporation devices

FDA 510(k) Submission Details - K062916

510(k) Number K062916 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 28, 2006
Decision Date October 23, 2006
Days to Decision 25 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
63d faster than avg
Panel avg: 88d · This submission: 25d
Pathway characteristics
Predicate-based equivalence.

JJY Device Classification - Class 1, General Controls

Product Code JJY Multi-analyte Controls, All Kinds (assayed)
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1660
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - JJY Multi-analyte Controls, All Kinds (assayed)

All 593
Devices cleared under the same product code (JJY) and FDA review panel - the closest regulatory comparables to K062916.
AUDIT MICROCV LIPIDS LINEARITY SET (LOW)
K070223 · Aalto Scientific, Ltd. · Mar 2007
COBAS INTEGRA CERULOPLASMIN
K062379 · Roche Diagnostics Corp. · Jan 2007
MISSION TRINITY B
K062674 · Diamond Diagnostics, Inc. · Dec 2006
AUDIT MICROCV IMMUNOASSAY LINEARITY SET
K062668 · Aalto Scientific, Ltd. · Oct 2006
ADVIA IMS CPSA CONTROL
K061137 · Bayer Healthcare, LLC · Jul 2006
CARDIOIMMUNE XL CARDIAC MARKER CONTROL
K061196 · Microgenics Corp. · May 2006